FATE : Summary for Fate Therapeutics, Inc. - Yahoo Finance

U.S. Markets open in 7 hrs 21 mins

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.99-0.06 (-1.97%)
At close: 4:00 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close3.05
Bid0.00 x
Ask0.00 x
Day's Range2.93 - 3.07
52 Week Range1.46 - 3.88
Avg. Volume195,323
Market Cap102.1M
PE Ratio (TTM)-2.69
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Fate Therapeutics Inc (FATE) Stock: Soaring On Financing And EU Approval
    Insider Monkey15 days ago

    Fate Therapeutics Inc (FATE) Stock: Soaring On Financing And EU Approval

    Shares in Fate Therapeutics Inc (NASDAQ:FATE) have soared today, gaining over 10% and reaching as high as $3.18 during the session. Why is Fate Soaring Fate Therapeutics Inc (NASDAQ:FATE) announced on Tuesday that it has entered into a definitive securities purchase agreement with certain institutional and other accredited investors. The deal was led by Redmile Group LLC, […]

  • GlobeNewswire16 days ago

    Fate Therapeutics Announces Private Financing

    SAN DIEGO, Nov. 22, 2016-- Fate Therapeutics, Inc., a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today announced that ...

  • Capital Cube28 days ago

    ETF’s with exposure to Fate Therapeutics, Inc. : November 10, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Fate Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to FATE-US. Comparing the performance and risk of Fate Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)